The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The agency ...
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its competition with Sanofi’s Qfitlia and Novo Nordisk’s Alhemo. After an FDA ...
(RTTNews) - Pfizer Inc. (PFE) has announced that a participant in the long-term extension trial evaluating Marstacimab in people living with hemophilia A or B with or without inhibitors has passed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results